Further study demonstrated that both LRIG3 and sLRIG3 inhibit the proliferation, migration and invasion of glioma cells by decreasing phosphorylation of MET and downstream signaling components in vitro and in vivo. The gene discussed is LRIG3; the disease is glioma.